ArticleJournal of neuro-oncology2026
Lower-grade glioma imaging volumes and survival: a single-institution analysis of 90 patients after resection using intraoperative MRI.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeExtent of resection (EOR) and residual tumor volume (RTV) are key prognostic factors in lower-grade gliomas (LGGs). Intraoperative magnetic resonance imaging (iMRI) enables real-time assessment of tumor removal, but the survival relevance of sequential volumetric measures remains incompletely defined. This study evaluated the relationship between T2- and FLAIR-based imaging volumes, EOR, and survival in patients undergoing LGG resection with iMRI with long-term radiographic and clinical follow-up.
methodsWe retrospectively reviewed 90 patients with WHO Grade 2-3 LGGs who underwent iMRI-guided resection between 2011 and 2023 at a single institution. Radiographic and clinical follow-up was tracked through 2025. Volumetric analyses were performed on preoperative, intraoperative, immediate postoperative, and three-month postoperative T2-weighted and FLAIR sequences. Associations between imaging volumes, EOR, and progression-free (PFS), malignant progression-free (mPFS), and overall (OS) survival were assessed using log-rank and multivariable Cox regression analyses, including subgroup analysis by isocitrate dehydrogenase (IDH) mutation status.
resultsMedian clinical and radiographic follow-up was 94.5 ± 34.8 months. Greater EOR correlated with longer survival across all metrics. In IDH-mutant tumors, FLAIR-based EOR was independently predictive of PFS (p ≤ 0.03), mPFS (p ≤ 0.02), and OS (p ≤ 0.02) on multivariable analysis. Additional resection after iMRI occurred in 55.6% of patients, with 90% yielding positive tumor margins, but did not independently improve survival.
conclusionIn LGG surgery accompanied by iMRI, greater EOR and smaller residual T2/FLAIR volumes predict longer survival, particularly among IDH-mutant tumors. The use of iMRI facilitates maximal safe resection.
Indexed as
Identifiers
41854942What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.